2024

The added value of (1,3)-β-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study
Christner M, Abdennadher B, Wichmann D, Kluge S, Pepić A, Aepfelbacher M, Rohde H, Olearo F
INFECTION. 2024;52(1):73-81.

Stepped, evidence-based and integrated care service model vs. usual care for mental disorders: a randomized controlled trial (RECOVER)
Lambert M, König H, Karow A, König H, Rohenkohl A, Luedecke D, Schröter R, Finter C, Tlach L, Schindler A, Peter H, Scherer M, Mews C, Härter M, Bindt C, Löwe B, Briken P, Peper H, Schweiger M, Mösko M, Bock T, Deister A, Correll C, Ozga A, Pepić A, Zapf A, Gallinat J, Peth J, Konnopka A, Schulz H
PSYCHIAT RES. 2024;339:116007.

Mind it! A mindfulness-based group psychotherapy for substance use disorders in adolescent inpatients
Legenbauer T, Baldus C, Jörke C, Kaffke L, Pepic A, Daubmann A, Zapf A, Holtmann M, Arnaud N, Thomasius R
EUR CHILD ADOLES PSY. 2024 [Epub ahead of print].

Effect of the i2TransHealth e-health intervention on psychological distress among transgender and gender diverse adults from remote areas in Germany: a randomised controlled trial
Nieder T, Renner J, Sehner S, Pepić A, Zapf A, Lambert M, Briken P, Dekker A
LANCET DIGIT HEALTH. 2024 [Epub ahead of print].

Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke
Nolte C, von Rennenberg R, Litmeier S, Leistner D, Szabo K, Baumann S, Mengel A, Michalski D, Siepmann T, Blankenberg S, Petzold G, Dichgans M, Katus H, Pieske B, Regitz-Zagrosek V, Braemswig T, Rangus I, Pepic A, Vettorazzi E, Zeiher A, Scheitz J, Wegscheider K, Landmesser U, Endres M
JAMA NEUROL. 2024;81(7):703-711.

A diagnostic phase III/IV seamless design to investigate the diagnostic accuracy and clinical effectiveness using the example of HEDOS and HEDOS II
Pepić A, Stark M, Friede T, Kopp-Schneider A, Calderazzo S, Reichert M, Wolf M, Wirth U, Schopf S, Zapf A
STAT METHODS MED RES. 2024;33(3):433-448.

The value of biomarkers in the therapy of CRSwNP with biologicals-a long-term follow-up of dupilumab therapy
Sarnoch S, Pepić A, Schmitz L, Becker B, Betz C, Hoffmann A
EUR ARCH OTO-RHINO-L. 2024;281(9):4789-4805.

Dialectical behavior therapy (DBT) in an assertive community treatment structure (ACT): testing integrated care borderline (ICB) in a randomized controlled trial (RECOVER)
Schindler A, Warkentin H, Bierbrodt J, König H, Konnopka A, Pepic A, Peth J, Lambert M, Gallinat J, Karow A, König H, Härter M, Schulz H, Rohenkohl A, Krog K, Biedermann S, Schäfer I
BORDER PERS DIS EMOT. 2024;11(1):18.

2023

Differentiation of acute non-ST elevation myocardial infarction and acute infarct-like myocarditis by visual pattern analysis: a head-to-head comparison of different cardiac MR techniques
Jahnke C, Sinn M, Hot A, Cavus E, Erley J, Schneider J, Chevalier C, Bohnen S, Radunski U, Meyer M, Lund G, Adam G, Kirchhof P, Blankenberg S, Muellerleile K, Tahir E
EUR RADIOL. 2023;33(9):6258-6266.

Dupilumab (Dupixent®) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany
Jansen F, Becker B, Eden J, Breda P, Hot A, Oqueka T, Betz C, Hoffmann A
EUR ARCH OTO-RHINO-L. 2023;280(4):1741-1755.

2022

Effectiveness of a complex regional advance care planning intervention to improve care consistency with care preferences
Götze K, Bausewein C, Feddersen B, Fuchs A, Hot A, Hummers E, Icks A, Kirchner Ä, Kleinert E, Klosterhalfen S, Kolbe H, Laag S, Langner H, Lezius S, Meyer G, Montalbo J, Nauck F, Reisinger C, Rieder N, Schildmann J, Schunk M, Stanze H, Vogel C, Wegscheider K, Zapf A, Marckmann G, in der Schmitten J
TRIALS. 2022;23(1):.

Sample size recalculation based on the prevalence in a randomized test-treatment study
Hot A, Benda N, Bossuyt P, Gerke O, Vach W, Zapf A
BMC MED RES METHODOL. 2022;22(1):.

Interdisciplinary, internet-based trans health care (i²TransHealth): study protocol for a randomised controlled trial
Nieder T, Renner J, Zapf A, Sehner S, Hot A, König H, Dams J, Grochtdreis T, Briken P, Dekker A
BMJ OPEN. 2022;12(2):e045980.

2021

Randomized test-treatment studies with an outlook on adaptive designs
Hot A, Bossuyt P, Gerke O, Wahl S, Vach W, Zapf A
BMC MED RES METHODOL. 2021;21(1):110.

2020

Evaluation of two family-based intervention programs for children affected by rare disease and their families – research network (CARE-FAM-NET): study protocol for a rater-blinded, randomized, controlled, multicenter trial in a 2x2 factorial design
Boettcher J, Filter B, Denecke J, Hot A, Daubmann A, Zapf A, Wegscheider K, Zeidler J, von der Schulenburg J, Bullinger M, Rassenhofer M, Schulte-Markwort M, Wiegand-Grefe S
BMC PRIM CARE. 2020;21(1):.

Marfan Syndrome Versus Bicuspid Aortic Valve Disease: Comparative Analysis of Obstetric Outcome and Pregnancy-Associated Immediate and Long-Term Aortic Complications
Toprak B, Szöcs K, Zengin-Sahm E, Sinning C, Hot A, Bannas P, Hecher K, Hüneke B, Mir T, Rybczynski M, Girdauskas E, Blankenberg S, von Kodolitsch Y
J CLIN MED. 2020;9(4):.

Letzte Aktualisierung aus dem FIS: 23.11.2024 - 03:30 Uhr